Glyxambi
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 2983
  • Home
  • Print this page
  • Email this page


 
   Table of Contents      
LETTER TO THE EDITOR
Year : 2018  |  Volume : 66  |  Issue : 1  |  Page : 173-174

Intravitreal bevacizumab


Consultants, Netralaya, Near Parimal Garden, Ambawadi, Ahmedabad, Gujarat, India

Date of Web Publication28-Dec-2017

Correspondence Address:
Dr. Bakulesh M Khamar
Former Professor of Opthalmology, NHL Municipal Medical College, 103, Elegance Tower, Ambawadi, Ellisbridge, Ahmedabad - 380 006, Gujarat
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijo.IJO_802_17

Rights and Permissions

How to cite this article:
Khamar BM. Intravitreal bevacizumab. Indian J Ophthalmol 2018;66:173-4

How to cite this URL:
Khamar BM. Intravitreal bevacizumab. Indian J Ophthalmol [serial online] 2018 [cited 2019 Sep 23];66:173-4. Available from: http://www.ijo.in/text.asp?2018/66/1/173/221862



Sir,

It was interesting reading the guest editorial and the special editorial in the July issue of IJO.[1]

I would like to point out that a pack of Lucentis includes 5 μ needle filter in spite of the fact that it contains a single dose. This is not provided with bevacizumab.

Five-micron filter provided with Lucentis will not allow administration of larger particles. Large particles are known to be formed with protein containing products such as bevacizumab.[2] Such particles are known to induce inflammation and sterile endophthalmitis.[3]

The use of 5 μ needle filter will probably help in avoiding sterile endophthalmitis (culture negative) which are also seen in a cluster, even when multiple doses are removed from the same vial in one sitting with due precautions.[3],[4]

Generally, bevacizumab is not known to be contaminated after multiple punctures, which has been demonstrated earlier by research.[5] However, if desired, potential contamination can also be eliminated using multidose vial adaptors as demonstrated by French investigators.[6] They used multidose vial adaptor having two distinct air and fluid channels. Air channel contains 0.45 μ air filter to prevent entry of microorganisms in a multidose vial and fluid channel containing 5 μ fluid filter to avoid withdrawal of large size particles.

Can this be recommended to take advantage of existing knowledge to provide affordable care to needy patients?

This is more pertinent now as we have more than one manufacturer of bevacizumab in our country.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Kumar A, Ravani R. Using intravitreal bevacizumab (Avastin ®) – Indian Scenario. Indian J Ophthalmol 2017;65:545-8.  Back to cited text no. 1
[PUBMED]  [Full text]  
2.
Kahook MY, Liu L, Ruzycki P, Mandava N, Carpenter JF, Petrash JM, et al. High-molecular-weight aggregates in repackaged bevacizumab. Retina 2010;30:887-92.  Back to cited text no. 2
[PUBMED]    
3.
Fielden M, Nelson B, Kherani A. Acute intraocular inflammation following intravitreal injection of bevacizumab – A large cluster of cases. Acta Ophthalmol 2011;89:e664-5.  Back to cited text no. 3
[PUBMED]    
4.
Entezari M, Ramezani A, Ahmadieh H, Ghasemi H. Batch-related sterile endophthalmitis following intravitreal injection of bevacizumab. Indian J Ophthalmol 2014;62:468-71.  Back to cited text no. 4
[PUBMED]  [Full text]  
5.
Das T, Volety S, Ahsan SM, Thakur AK, Sharma S, Padhi TR, et al. Safety, sterility and stability of direct-from-vial multiple dosing intravitreal injection of bevacizumab. Clin Exp Ophthalmol 2015;43:466-73.  Back to cited text no. 5
    
6.
Le Rouic JF, Breger D, Peronnet P, Hermouet-Leclair E, Alphandari A, Pousset-Decré C, et al. Extemporaneous withdrawal with a mini-spike filter: A low infection risk technique for drawing up bevacizumab for intravitreal injection. J Fr Ophtalmol 2016;39:415-20.  Back to cited text no. 6
    




 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
References

 Article Access Statistics
    Viewed1258    
    Printed1    
    Emailed0    
    PDF Downloaded95    
    Comments [Add]    

Recommend this journal